The following is a guest post from Devesh Kumar, senior director at EY-Parthenon. Opinions are the author’s own.
Ask any CFO to recite the line-item advisory fees on their last sizable acquisition, and you will get a precise answer: banker success fees, legal fees by firm, diligence retainers, tax advisory and regulatory counsel. Now ask the same CFO for the approved budget for the first 12 months of post-close integration. The answer, in my experience across large transactions, is often some variation of: We’ll figure that out after close.
In a complex $2 billion strategic acquisition, total transaction advisory fees can easily run into the tens of millions of dollars, and the budget for bankers, lawyers, diligence providers, tax advisers and regulatory counsel is approved with precision. The first-year integration budget — the money that actually determines whether the deal delivers its announced synergies — is often a fraction of that amount, assembled piecemeal from functional budgets and rarely approved as a single line item.
This is the post-merger integration investment gap. It is one of the most consequential and most fixable capital allocation errors in corporate finance, and it sits squarely within the CFO’s span of control.
Why the math has gotten worse
The gap is not new, but it has become more expensive. The WTW/Bayes Business School Quarterly Deal Performance Monitor, which has tracked acquirer share-price performance against regional indices since 2008, shows how volatile and unforgiving M&A value creation can be: Buyers have underperformed materially in some recent periods, even as other periods have shown recovery.
What has changed is the cost of getting integration wrong. With risk-free rates and corporate hurdle rates materially higher than they were during the zero-rate M&A cycle, the value lost to delayed synergy capture has become much more expensive. A synergy case that slips by a quarter or two is no longer a rounding error in the model; it is a visible erosion of deal value.
The root cause is structural, not analytical. Advisory fees are front-loaded, externally negotiated and visible as a discrete capital commitment. Integration spend is distributed — part sits in HR and surfaces as severance accruals, part sits in IT and folds into ERP migration costs and part sits in commercial and disappears into sales operations. No single person sizes the whole thing, and there is often no internal benchmark to anchor the discussion. By the time the CFO notices announced synergies slipping, the investment window during which targeted incremental spend would have changed the trajectory has often closed.
The integration investment ratio
One reason the gap persists is that CFOs lack a simple metric to anchor the conversation. A useful internal measure is the integration investment ratio: the total approved first-year integration spend divided by the announced run-rate synergy value.
The integration investment ratio is not a universal rule. Deal size, complexity, geography, regulatory constraints, transition service agreement dependence, technology separation and commercial overlap all justify deviations. But it is the conversation-starter CFOs need at deal approval, before the transaction closes and it becomes four months too late to fund the work properly.
Assuming the CFO wins the argument for a well-funded integration program, these three categories deliver outsized returns:
1. Dedicated commercial execution capability. A commercial integration office, effectively a commercial workstream within the broader integration management office, led by a senior executive with dedicated analytics, sales-operations and customer-retention support. The budget should cover the specialist support required in the first 90 days, including customer interview programs, sales-force coaching, customer-retention planning, channel conflict management and compensation plan redesign. In many synergy-led transactions, this category alone can justify several percentage points of internal rate of return because it protects the revenue assumptions that often determine whether the deal thesis survives contact with the market.
2. Clean-room-based pre-close synergy validation. The sign-to-close window is often the single best opportunity to pressure-test commercial synergies, but it is routinely underused. A properly scoped clean room, staffed by independent third-party advisers and governed by documented information-barrier protocols designed to prevent improper exchange of competitively sensitive information, can validate the synergy hypothesis before day one and produce an execution-ready plan when the deal closes. In a deal with $500 million of annual run-rate synergies, accelerating capture by 90 days can pull forward roughly one quarter of annualized benefit before discounting and taxes — a prize that can dwarf a clean-room investment in the low single-digit millions.
3. Value-capture instrumentation. The dashboards, data pipes and reporting cadences that let the integration leader see weekly, not quarterly, where capture is on plan and where it is slipping. Generative AI and modern data-engineering tools have lowered the practical burden of building this infrastructure, but the CFO should treat them as accelerants, not substitutes, for disciplined value-capture governance. The job is not to create another reporting package. It is to make sure that weekly tracking is operational on day one, not the second quarter after close.
What CFOs and audit committees should do now
These four actions matter most.
1. At deal approval, require a discrete first-year integration budget line item, benchmarked against announced synergy value using the internal rate of return framework and approved alongside the advisory fee budget rather than after close.
2. Name a single integration budget owner — typically the integration leader or commercial integration lead — accountable for the spend and for communicating deviations monthly. Without a named owner, the budget disperses into functional line items and stops existing as a managed number.
3. Require weekly leading-indicator reporting, not quarterly synergy-attainment summaries, for the first 180 days post-close. Most year-one commercial decisions are made in weeks four through sixteen, well before the first quarterly update.
4. Disclose integration investment adequacy to the board at deal approval. If the proposed budget is meaningfully below the internal rate of return benchmark, directors should understand why. In some cases, the right answer may be that the deal requires less investment because the integration is narrow, the operating model is unchanged or the synergy case is modest. In other cases, an underfunded integration plan should force a harder conversation about the deal model itself.
The post-merger integration investment gap is not a glamorous problem. It is the capital allocation decision that gets made by default, in the quiet period between signing and closing, when finance is stretched thin and the integration team has not yet fully stood up. That is precisely why it is so consequential: Default decisions compound.
Acquirers who close the gap will compound returns on their M&A programs visibly within two to three deal cycles. Acquirers who do not will find that each announced deal faces harder analyst skepticism, more pointed activist questions and a higher bar from their own boards. CFOs who want their organizations on the right side of that split should treat integration budgeting not as a post-close administrative task, but as one of the most important capital allocation decisions they make in any given deal.
